[go: up one dir, main page]

EA200900008A1 - Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов - Google Patents

Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов

Info

Publication number
EA200900008A1
EA200900008A1 EA200900008A EA200900008A EA200900008A1 EA 200900008 A1 EA200900008 A1 EA 200900008A1 EA 200900008 A EA200900008 A EA 200900008A EA 200900008 A EA200900008 A EA 200900008A EA 200900008 A1 EA200900008 A1 EA 200900008A1
Authority
EA
Eurasian Patent Office
Prior art keywords
production
tlterodine
phesotorodine
active metabolites
application
Prior art date
Application number
EA200900008A
Other languages
English (en)
Other versions
EA018376B1 (ru
Inventor
Клаус Меезе
Original Assignee
Шварц Фарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шварц Фарма Аг filed Critical Шварц Фарма Аг
Publication of EA200900008A1 publication Critical patent/EA200900008A1/ru
Publication of EA018376B1 publication Critical patent/EA018376B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/12—Formation of amino and carboxyl groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

Предложено соединение формулы (I)Оно может быть получено путем проведения реакции восстановления соединения формулы (IV)где R представляет собой водород, прямой или разветвленный C-С-алкил. Это соединение представляет собой ценный промежуточный продукт, который может быть использован в синтезе фезотеродина, толтеродина, их активных метаболитов и родственных соединений.
EA200900008A 2006-06-12 2007-06-06 Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов EA018376B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06012052 2006-06-12
PCT/EP2007/005008 WO2007144097A1 (en) 2006-06-12 2007-06-06 New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof

Publications (2)

Publication Number Publication Date
EA200900008A1 true EA200900008A1 (ru) 2009-06-30
EA018376B1 EA018376B1 (ru) 2013-07-30

Family

ID=36764900

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200900008A EA018376B1 (ru) 2006-06-12 2007-06-06 Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов

Country Status (16)

Country Link
US (3) US7982058B2 (ru)
EP (1) EP2027103B1 (ru)
JP (1) JP5220737B2 (ru)
KR (2) KR20140010198A (ru)
CN (1) CN101466695B (ru)
AU (1) AU2007260267B2 (ru)
BR (1) BRPI0712842A2 (ru)
CA (1) CA2647990C (ru)
DK (1) DK2027103T3 (ru)
EA (1) EA018376B1 (ru)
ES (1) ES2464868T3 (ru)
MX (1) MX2008015973A (ru)
PL (1) PL2027103T3 (ru)
PT (1) PT2027103E (ru)
SI (1) SI2027103T1 (ru)
WO (1) WO2007144097A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2007260267B2 (en) * 2006-06-12 2012-09-06 Ucb Pharma Gmbh New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
EP2364966A1 (en) 2010-03-09 2011-09-14 LEK Pharmaceuticals d.d. Process for preparation of 3-(2-hydroxy-5-substituted phenyl)-3-phenylpropylamines, intermediates for making hydroxytolterodine
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
IT1403094B1 (it) * 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
CN103193747A (zh) * 2013-04-18 2013-07-10 中国药科大学 一种富马酸弗斯特罗定中间体的制备方法
KR20230042887A (ko) 2021-09-23 2023-03-30 주식회사 두비컴퓨팅 서버 랙

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8800207D0 (sv) 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE19955190A1 (de) 1999-11-16 2001-06-21 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
SE9904850D0 (sv) 1999-12-30 1999-12-30 Pharmacia & Upjohn Ab Novel process and intermediates
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DK2029567T3 (da) * 2006-05-24 2010-11-29 Pfizer Ltd Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
AU2007260267B2 (en) * 2006-06-12 2012-09-06 Ucb Pharma Gmbh New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof

Also Published As

Publication number Publication date
AU2007260267B2 (en) 2012-09-06
US8742140B2 (en) 2014-06-03
JP5220737B2 (ja) 2013-06-26
KR20140010198A (ko) 2014-01-23
DK2027103T3 (da) 2014-04-22
US20090192224A1 (en) 2009-07-30
MX2008015973A (es) 2009-01-12
EA018376B1 (ru) 2013-07-30
EP2027103B1 (en) 2014-02-26
CA2647990C (en) 2014-02-04
CA2647990A1 (en) 2007-12-21
US20110245338A1 (en) 2011-10-06
KR20090016451A (ko) 2009-02-13
WO2007144097A1 (en) 2007-12-21
AU2007260267A1 (en) 2007-12-21
SI2027103T1 (sl) 2014-07-31
CN101466695A (zh) 2009-06-24
US9309215B2 (en) 2016-04-12
ES2464868T3 (es) 2014-06-04
KR101488740B1 (ko) 2015-02-03
JP2009539901A (ja) 2009-11-19
PT2027103E (pt) 2014-05-02
BRPI0712842A2 (pt) 2012-07-24
PL2027103T3 (pl) 2014-12-31
EP2027103A1 (en) 2009-02-25
US20140228434A1 (en) 2014-08-14
US7982058B2 (en) 2011-07-19
CN101466695B (zh) 2012-06-27

Similar Documents

Publication Publication Date Title
EA201201179A1 (ru) Способ получения изоксазолиновых производных
EA200900008A1 (ru) Новые хиральные промежуточные продукты, способ их получения и их применение в производстве толтеродина, фезотеродина или их активных метаболитов
UA102817C2 (ru) Способ синтеза агомелатина
GEP20125512B (en) Process for synthesis of agomelatin
BRPI0813284A8 (pt) Processo para a preparação de um composto da fórmula (i) e composto
WO2009035130A3 (en) Process for producing 2,3,3,3-tetrafluoropropene
MX2010009860A (es) Sintesis total de salinosporamida a y sus analogos.
SG165380A1 (en) Process for the production of amides
ATE477234T1 (de) Synthese von phenolischen estern von hydroxymethylphenolen
EA201000257A1 (ru) Новый способ синтеза (7-метокси-l-нафтил) ацетонитрила и применение в синтезе агомелатина
TN2009000401A1 (en) New methods
WO2011077140A3 (en) Method of producing acrylic and methacrylic acid
EA200900090A1 (ru) Бензиламины, способ их получения и их применение в качестве противовоспалительных средств
UA106195C2 (ru) Способ синтеза агомелатина
TW200612959A (en) Method for preparing hydroxamic acids
UA102816C2 (ru) Способ синтеза кристаллической формы v агомелатина
ITMI20050550A1 (it) Procedimento per la preparazione di adapalene
WO2012113999A8 (fr) Procede et intermediaires de synthese de l ' agomelatine
BRPI0507318A (pt) métodos para reduzir um composto, para a produção de calcipotriol ou monoidrato de calcipotriol, e de um composto, e de reação da mistura de compostos, composto, e, uso de um composto
TW200738650A (en) Process for synthesis of aryloxy diaminopyrimidines
UA93860C2 (ru) Способ получения пиразолов, способ региоселективного алкилирования и применение фосфата или фосфоната b способе
MA32698B1 (fr) Procede de preparation du 1,6:2,3-dianhydro-beta-d-mannopyranose
WO2011151442A3 (en) Process for producing aliskiren
AR062623A1 (es) Proceso quimico
TH128482B (th) กระบวนการแบบใหม่สำหรับการสังเคราะห์ไอวาบราดีนและเกลือที่ได้จากการเติมของสิ่งนั้นด้วยกรดที่สามารถยอมรับได้ทางเภสัชกรรม